NCT00978575View on ClinicalTrials.gov

Iron Substitution After Upper Gastro-Intestinal Bleeding

PHASE4CompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

January 31, 2013

Study Completion Date

April 30, 2013

Conditions
Gastrointestinal HemorrhageAnemia
Interventions
DRUG

ferricarboxymaltose

Single dose of maximum 1000 mg ferricarboxymaltose intravenous

DRUG

Ferrosulfate

200mg daily for 12 weeks

DRUG

Placebo

100 mg isotonic sodium and 2 placebo tablets daily

Trial Locations (1)

8000

Aarhus University Hospital, Aarhus

Sponsors

Collaborators (1)

Vifor Pharma
All Listed Sponsors
collaborator

GCP-unit at Aarhus University Hospital, Aarhus, Denmark

OTHER

collaborator

Vifor Pharma

INDUSTRY

lead

University of Aarhus

OTHER

NCT00978575 - Iron Substitution After Upper Gastro-Intestinal Bleeding | Biotech Hunter | Biotech Hunter